论文信息 - Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial. - 字舞流文

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.

H. Rugo | P. Ott | S. Piha-Paul | R. Rangwala | B. O'Neil | A. Varga | S. Saraf | C. Gomez-Roca | E. V. van Brummelen | J. Frenel | C. le Tourneau | E. van Brummelen | S. Thomas | Reshma A. Rangwala